Novel rapid intraoperative qualitative tumor detection by a residual convolutional neural network using label-free stimulated Raman scattering microscopy.


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
06 08 2022
Historique:
received: 23 05 2022
accepted: 17 07 2022
entrez: 6 8 2022
pubmed: 7 8 2022
medline: 10 8 2022
Statut: epublish

Résumé

Determining the presence of tumor in biopsies and the decision-making during resections is often dependent on intraoperative rapid frozen-section histopathology. Recently, stimulated Raman scattering microscopy has been introduced to rapidly generate digital hematoxylin-and-eosin-stained-like images (stimulated Raman histology) for intraoperative analysis. To enable intraoperative prediction of tumor presence, we aimed to develop a new deep residual convolutional neural network in an automated pipeline and tested its validity. In a monocentric prospective clinical study with 94 patients undergoing biopsy, brain or spinal tumor resection, Stimulated Raman histology images of intraoperative tissue samples were obtained using a fiber-laser-based stimulated Raman scattering microscope. A residual network was established and trained in ResNetV50 to predict three classes for each image: (1) tumor, (2) non-tumor, and (3) low-quality. The residual network was validated on images obtained in three small random areas within the tissue samples and were blindly independently reviewed by a neuropathologist as ground truth. 402 images derived from 132 tissue samples were analyzed representing the entire spectrum of neurooncological surgery. The automated workflow took in a mean of 240 s per case, and the residual network correctly classified tumor (305/326), non-tumorous tissue (49/67), and low-quality (6/9) images with an inter-rater agreement of 89.6% (κ = 0.671). An excellent internal consistency was found among the random areas with 90.2% (Cα = 0.942) accuracy. In conclusion, the novel stimulated Raman histology-based residual network can reliably detect the microscopic presence of tumor and differentiate from non-tumorous brain tissue in resection and biopsy samples within 4 min and may pave a promising way for an alternative rapid intraoperative histopathological decision-making tool.

Identifiants

pubmed: 35933416
doi: 10.1186/s40478-022-01411-x
pii: 10.1186/s40478-022-01411-x
pmc: PMC9356422
doi:

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109

Informations de copyright

© 2022. The Author(s).

Références

Arch Pathol Lab Med. 1997 Jun;121(6):559-67
pubmed: 9199619
J Clin Med. 2021 May 10;10(9):
pubmed: 34068592
Lancet Oncol. 2006 May;7(5):392-401
pubmed: 16648043
Neurosurgery. 2022 Jun 1;90(6):758-767
pubmed: 35343469
World Neurosurg. 2016 Aug;92:255-263
pubmed: 27178235
Laryngoscope. 2004 Feb;114(2):266-72
pubmed: 14755201
Lancet Oncol. 2015 Sep;16(11):1193-224
pubmed: 26427363
Front Oncol. 2020 Dec 04;10:599250
pubmed: 33344251
Front Oncol. 2021 Feb 08;10:618837
pubmed: 33628733
Cancer Res. 2018 Jan 1;78(1):278-289
pubmed: 29093006
J Neurosurg. 2012 Apr;116(4):854-60
pubmed: 22283191
Neurosurg Clin N Am. 2021 Jan;32(1):47-54
pubmed: 33223025
J Neurooncol. 2015 Apr;122(2):367-82
pubmed: 25630625
Ann Surg. 2017 Feb;265(2):300-310
pubmed: 27429028
Nat Biomed Eng. 2017;1:
pubmed: 28955599
J Neurosurg Sci. 2016 Sep;60(3):350-6
pubmed: 26824195
J Neurooncol. 2021 Feb;151(3):393-402
pubmed: 33611706
Am J Clin Pathol. 2021 Aug 4;156(3):461-470
pubmed: 33728460
Science. 2008 Dec 19;322(5909):1857-61
pubmed: 19095943
J Neurooncol. 2021 Feb;151(3):479-490
pubmed: 33611714
Mol Cell Oncol. 2020 Apr 1;7(3):1736742
pubmed: 32391430
Front Oncol. 2018 Mar 26;8:74
pubmed: 29632850
J Neurol Surg A Cent Eur Neurosurg. 2013 Mar;74(2):71-6
pubmed: 23404553
Neuro Oncol. 2021 Jan 30;23(1):144-155
pubmed: 32672793
Neurosurgery. 2002 Apr;50(4):804-12; discussion 812
pubmed: 11904032
Nat Med. 2020 Jan;26(1):52-58
pubmed: 31907460

Auteurs

David Reinecke (D)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. david.reinecke@uk-koeln.de.

Niklas von Spreckelsen (N)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Christian Mawrin (C)

Department of Neuropathology, Otto-von-Guericke University, Magdeburg, Germany.
Center for Behavioral Brain Sciences (CBBS), Otto-von-Guericke University, Magdeburg, Germany.

Adrian Ion-Margineanu (A)

Invenio Imaging Inc., Santa Clara, CA, USA.

Gina Fürtjes (G)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Stephanie T Jünger (ST)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Department of Stereotactic and Functional Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Florian Khalid (F)

Invenio Imaging Inc., Santa Clara, CA, USA.

Christian W Freudiger (CW)

Invenio Imaging Inc., Santa Clara, CA, USA.

Marco Timmer (M)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Maximilian I Ruge (MI)

Centre for Integrated Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Department of Stereotactic and Functional Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Roland Goldbrunner (R)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Centre for Integrated Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Volker Neuschmelting (V)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. volker.neuschmelting@uk-koeln.de.
Centre for Integrated Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. volker.neuschmelting@uk-koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH